303 related articles for article (PubMed ID: 22977010)
1. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.
Yang C; Talukder MA; Varadharaj S; Velayutham M; Zweier JL
Cardiovasc Res; 2013 Jan; 97(1):33-43. PubMed ID: 22977010
[TBL] [Abstract][Full Text] [Related]
2. The significance of the washout period in preconditioning.
Salie R; Lochner A; Loubser DJ
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
4. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.
Vladic N; Ge ZD; Leucker T; Brzezinska AK; Du JH; Shi Y; Warltier DC; Pratt PF; Kersten JR
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2130-9. PubMed ID: 21908789
[TBL] [Abstract][Full Text] [Related]
5. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
Li XD; Yang YJ; Geng YJ; Zhao JL; Zhang HT; Cheng YT; Wu YL
Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
[TBL] [Abstract][Full Text] [Related]
7. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
[TBL] [Abstract][Full Text] [Related]
8. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.
Inserte J; Hernando V; Vilardosa Ú; Abad E; Poncelas-Nozal M; Garcia-Dorado D
J Am Heart Assoc; 2013 Jan; 2(1):e005975. PubMed ID: 23525447
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
11. Delayed preconditioning prevents ischemia/reperfusion-induced endothelial injury in rats: role of ROS and eNOS.
He X; Zhao M; Bi XY; Yu XJ; Zang WJ
Lab Invest; 2013 Feb; 93(2):168-80. PubMed ID: 23147223
[TBL] [Abstract][Full Text] [Related]
12. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
13. Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling.
Liu Q; Li Z; Liu Y; Xiao Q; Peng X; Chen Q; Deng R; Gao Z; Yu F; Zhang Y
Cardiovasc Ther; 2018 Dec; 36(6):e12481. PubMed ID: 30597772
[TBL] [Abstract][Full Text] [Related]
14. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning.
Amour J; Brzezinska AK; Weihrauch D; Billstrom AR; Zielonka J; Krolikowski JG; Bienengraeber MW; Warltier DC; Pratt PF; Kersten JR
Anesthesiology; 2009 Feb; 110(2):317-25. PubMed ID: 19194158
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
Yasuda S; Kobayashi H; Iwasa M; Kawamura I; Sumi S; Narentuoya B; Yamaki T; Ushikoshi H; Nishigaki K; Nagashima K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1558-65. PubMed ID: 19286954
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
[TBL] [Abstract][Full Text] [Related]
17. Loss of ischaemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C epsilon phosphorylation.
Shinmura K; Nagai M; Tamaki K; Bolli R
Cardiovasc Res; 2008 Aug; 79(3):387-94. PubMed ID: 18390563
[TBL] [Abstract][Full Text] [Related]
18. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.
Baotic I; Ge ZD; Sedlic F; Coon A; Weihrauch D; Warltier DC; Kersten JR
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H219-27. PubMed ID: 23666677
[TBL] [Abstract][Full Text] [Related]
20. Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning.
Ciocci Pardo A; Scuri S; González Arbeláez LF; Caldiz C; Fantinelli J; Mosca SM
Cardiovasc Pathol; 2018; 33():19-26. PubMed ID: 29414428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
